
zzso injection zzso is a new zzso zzso contrast agent for which the safety at the dose zzso zzso was evaluated during a European zzso study on a large population of adult patients who had an MR examination of the central nervous system with contrast zzso The safety analysis was performed on zzso patients by recording the adverse events observed during injection and up to 24 hours after the zzso zzso events due or probably due to zzso injection were observed in 102 patients zzso with zzso associated discomfort zzso zzso pain at the injection zzso in 37 patients zzso and adverse events other than discomfort zzso zzso zzso in 35 patients zzso No adverse events of severe intensity or death were reported during the zzso zzso injection was shown to be safe and well tolerated and represents a zzso alternative to the current products in the field of MR imaging of the central nervous zzso 

